OBREDON (GUAIFENESIN; HYDROCODONE BITARTRATE) — FDA Approval NDA205474 (SOVEREIGN PHARMS)
OBREDON (GUAIFENESIN; HYDROCODONE BITARTRATE) — FDA Approval NDA205474 (SOVEREIGN PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OBREDON; Active ingredients: GUAIFENESIN; HYDROCODONE BITARTRATE; Application number: NDA205474.
| Brand name | OBREDON |
|---|---|
| Active ingredients | GUAIFENESIN; HYDROCODONE BITARTRATE |
| Application number | NDA205474 |
| Sponsor | SOVEREIGN PHARMS |
| Dosage form | SOLUTION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20141114 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →